Changeflow GovPing Healthcare & Life Sciences US20260108577A1: Biotic Superparamagnetic Nanop...
Routine Notice Added Final

US20260108577A1: Biotic Superparamagnetic Nanoparticles from Colchicum Ritchii

Email

Summary

USPTO published patent application US20260108577A1 on April 23, 2026, disclosing a method for preparing biotic superparamagnetic nanoparticles using Colchicum ritchii plant extract combined with ferric chloride solution and sodium hydroxide solution. The application names VEERAMANI CHINNADURAI, KHALID S. AL-NUMAIR, and MOHAMMED A. ALSAIF as inventors, with a filing date of October 17, 2024, and application number 18918527. CPC classifications indicate pharmaceutical applications including weight management (A61P 3/04) and diabetes treatment (A61P 3/10).

“A method of preparing biotic super-paramagnetic nanoparticles can include combining a Colchicum ritchii plant extract with a ferric chloride solution to provide a mixture and adding sodium hydroxide solution to the mixture to provide the super-paramagnetic nanoparticles.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.

What changed

USPTO published patent application US20260108577A1 disclosing a method for preparing biotic superparamagnetic nanoparticles using Colchicum ritchii plant extract, ferric chloride solution, and sodium hydroxide. The application includes CPC classifications indicating pharmaceutical applications for weight management and diabetes treatment.

Inventors and potential patent applicants should be aware that this publication establishes a priority date of October 17, 2024, and the disclosed method is now publicly available as prior art. Parties developing similar nanoparticle synthesis methods should conduct freedom-to-operate analyses.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHOD FOR PREPARING BIOTIC SUPERPARAMAGNETIC NANOPARTICLES DERIVED FROM COLCHICUM RITCHII

Application US20260108577A1 Kind: A1 Apr 23, 2026

Inventors

VEERAMANI CHINNADURAI, KHALID S. AL-NUMAIR, MOHAMMED A. ALSAIF

Abstract

A method of preparing biotic super-paramagnetic nanoparticles can include combining a Colchicum ritchii plant extract with a ferric chloride solution to provide a mixture and adding sodium hydroxide solution to the mixture to provide the super-paramagnetic nanoparticles.

CPC Classifications

A61K 36/88 A61K 9/5115 A61K 9/5192 A61K 47/02 A61P 3/04 A61P 3/10

Filing Date

2024-10-17

Application No.

18918527

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Investors Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application Nanoparticle synthesis Pharmaceutical formulation
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices Product Safety

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!